Coronary Vasospasm in a Patient With Argininosuccinic Aciduria

Am J Cardiol. 2023 Apr 1:192:155-159. doi: 10.1016/j.amjcard.2023.01.036. Epub 2023 Feb 18.

Abstract

A 39-year-old male was referred for treatment of hypertension. He had been treated for argininosuccinic aciduria since 8 months of age. Therapeutic drugs, including l-arginine, sodium phenylbutyrate, and antiepileptic drugs, had been prescribed. A detailed medical history revealed that he complained of chest discomfort under psychologic stress. A 12-lead electrocardiogram showed abnormal q waves in lead III and aVF. Transthoracic echocardiography showed hypokinesia of the left ventricular posterior wall. The patient was diagnosed with myocardial infarction because of coronary vasospastic angina by intracoronary acetylcholine provocation test. Argininosuccinic aciduria is a genetic disorder of the urea cycle caused by a deficiency of argininosuccinate lyase. Reduction of the enzymatic activity leads to a decrease in nitric oxide production, even if arginine is supplemented. Our case report supports the significance of endothelial function in the pathogenesis of coronary vasospasm.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Angina Pectoris
  • Arginine
  • Argininosuccinate Lyase / genetics
  • Argininosuccinic Aciduria* / diagnosis
  • Argininosuccinic Aciduria* / genetics
  • Argininosuccinic Aciduria* / therapy
  • Coronary Vasospasm*
  • Humans
  • Male

Substances

  • Argininosuccinate Lyase
  • Arginine